Our subgroup analysis identified CK7 expression as a significant predictor of poor survival in LCNEC patients, with the CK7-positive individuals exhibiting markedly reduced mean survival compared to their CK7-negative counterparts (Figure 3). The gene discussed is KRT7; the disease is large cell neuroendocrine carcinoma.